Dr. Noel A. Maun, MD, PhD

Dr. Maun practices at Venice Regional Bayfront Health in Venice, Florida.

Dr. Maun's NPI, 1518940246, was assigned on November 28, 2005. Dr. Maun graduated from University Of Florida College Of Medicine in 1995. Dr. Maun holds Florida license ME84976.

Dr. Maun's primary practice is Venice Regional Bayfront Health, at 540 The Rialto, Venice, FL 34285 in Sarasota County. The practice phone is (941) 483-7773.

Dr. Maun's primary practice is Venice Regional Bayfront Health in Venice, Florida. Dr. Maun is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Maun to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Maun practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Maun's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Maun is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Maun's licenses on file in 2 states: Florida and Connecticut.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, fluid and electrolyte imbalances, immune deficiency disease and lung cancer among the conditions Dr. Maun treats.

CMS data shows 384,087 Medicare services from Dr. Maun across 71 procedure codes in 2024, for 1,400 Medicare patients. Medicare paid $3,460,228 for them.

CMS counts 1,400 Medicare patients who saw Dr. Maun in 2024. The largest group is 75 to 84, with 637 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Maun's median patient age at 74, with 59% women.

In 2024, Dr. Maun wrote 1,255 Medicare Part D claims for 259 patients. 69% of them were for generic drugs. CMS names the drug for 1,051 of them, across 35 drugs with 11 or more claims each, at $4,012,192 in total drug cost. In 2023, CMS named 981 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Maun for performance year 2024, reported as part of a group. Dr. Maun accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Maun in 2003. The most frequent topics are Cell Differentiation, Cell Line and Granulocyte-Macrophage Colony-Stimulating Factor. Dr. Maun has published most often in Blood. Dr. Maun's most frequent co-authors are Nancy Berliner, MD, Lia E. Perez, MD and Murat Osman Arcasoy, MD.

CMS Open Payments shows 307 general payments to Dr. Maun from 48 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Merck Sharp & Dohme Corporation paid the most, $646.

Dmand AI lists 1 award for Dr. Maun, most recently CMS Stage 1 EHR in 2014.

Dr. Maun graduated from University Of Florida College Of Medicine in 1995. Dr. Maun is a member of ASCO.

Dr. Maun is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.